Top 10 Biotech Startup Investors in Latvia in April 2025
A list of 10 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Latvia. We rank investors based on the number of investments they made in Biotech companies from Latvia. We update this investor list every month.Top 10 Biotech Startup Investors in Latvia in April 2025
Investor | Biotech Latvia investments |
---|---|
Imprimatur Capital Fund Management | 6 |
Qiming Venture Partners USA | 2 |
Abingworth | 2 |
SOSV | 2 |
FlyCap | 2 |
ZGI Capital | 1 |
Roche Venture Fund | 1 |
Citadel | 1 |
TSVC | 1 |
Alexandria Venture Investments | 1 |
Imprimatur Capital Fund Management is a venture capital firm focusing on high-technology at an early stage in its commercial development. We invest in start-up technology businesses which are based on innovative intellectual property, are led by strong teams and have high international growth potential.Imprimatur Capital Fund Management, based inLatvia, manages seed and start-up funds with investors including the Latvian Guarantee Agency, other institutional investors and some private investors. The company source investment opportunities primarily from the Baltic/Nordic/Russia region.Imprimatur Capital Fund Management is a partner firm of Imprimatur Capital Ltd, headquartered in London and with investment operations in Europe, Russia, Asia Pacific, Latin America and the US.
Show more
Investment focus
- Software, Information Technology, Apps
- Seed, Debt Financing, Funding Round
- Latvia, United States, United Kingdom
Portfolio highlights
- Axial3D — Leading the way with the latest 3D imaging, models, and devices
- afriQloud — AfriQloud provides a white-labeled cloud computing solution to telecom operators, internet service providers, system integrators, and managed information technology service providers.
- Sonarworks — SoundID Reference software calibrates your speakers and studio headphones, so you can trust that every mix will translate.
Qiming Venture Partners USA, founded in 2017, is a healthcare venture capital firm and healthcare investor with deep technical expertise that allows them to identify tomorrow's innovations early and strong operational experience with a hands-on approach that makes us the investor of choice for early-stage biotech companies.Because of theirproven, hands-on approach to supporting CEOs and scaling operations, its partners are frequently sought after to serve on company boards. They are respected business and thought leaders.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Post-IPO Equity
- United States, Canada, China
Portfolio highlights
- Umoja Biopharma — Pioneering immunotherapy by reprogramming T cells in vivo to target cancer cells.
- Auron Therapeutics — A differentiated approach to cure cancer.
- Tenpoint Therapeutics — Tenpoint Therapeutics Ltd. is a global, clinical-stage biotech company developing groundbreaking treatments to rejuvenate vision in the aging eye.
We are Abingworth, a trans-atlantic bio-science investment firm with a deep understanding of both the science and markets we invest in.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series B, Series A, Series C
- United States, United Kingdom, France
Portfolio highlights
- AdvanCell — AdvanCell is an Australian radiopharmaceutical firm in the clinical stages that has developed the Targeted Alpha Therapy platform technology, a cutting-edge cancer treatment.
- Myricx Bio — Myricx Pharma is a small molecule drug discovery company engaged in developing novel proprietary inhibitors of human N-myristoyltransferases (NMT), with a primary focus in oncology but also exploring potential applications across other diseases.
- Timberlyne Therapeutics — Taking Best-in-Class Therapies to New Heights Our mission is to bring life-changing medicines to patients living with autoimmune diseases. About Us Timberlyne Therapeutics is a clinical-stage biopharmaceutical company focused on the development and commercialization of transformational therapies for autoimmune diseases. We are leveraging the extensive drug development expertise
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates.
HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Seed, Convertible Note, Pre-Seed
- United States, India, United Kingdom
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
FlyCap AIF is a Venture Capital Fund of total size of 15.75 MEUR. The Fund provides growth capital for Latvia based SME’s in a form of investments in equity and mezzanine capital.
Show more
Investment focus
- Health Care, Consumer Goods, Medical
- Funding Round, Seed, Debt Financing
- Latvia, Estonia, The Netherlands
Portfolio highlights
- Tapcore — Tapcore is the only solution on the market that enables mobile developers to monetize pirated copies of their apps through advertising. Established in 2015, we are a remote company with headquarters in the Netherlands. Currently we serve over 150 million ad requests daily (and counting!).
- Purified — Purified is a nutritional supplement supplier.. It offers black chocolate produced by the best doctors in collaboration with scientists.
- Elmo — In our car sharing business Elmo Rent we wanted to serve maximum customers with minimum resources, so we created remote control technology to deliver vehicles.
ZGI Capital is the fund management company that manages "ZGI fund”, that was founded to support entrepreneurs lacking start-up capital for their business. The total amount of assets available for venture capital investments is of EUR 7.4M. Combined with bank financing, this will allow to finance investment projects with total assets of up toEUR 30M. The fund acts on behalf of various investors including the State.
Show more
Investment focus
- Manufacturing, Machinery Manufacturing, Consulting
- Funding Round, Seed, Debt Financing
- Latvia, Estonia
Portfolio highlights
- eAgronom — eAgronom helps farmers generate additional revenue streams, improve soil quality, and access better financing.
- KOOL Latvija — "KOOL Latvija" is a new concept gas station created in Latvia, which at the same time is also a convenient fast shopping place.
- Bioreactors.net — Biotechnical center is an innovative company and we provide solutions for industrial biotechnology processes, bioreactor manufacturing and industrial automation. We manufacture bioreactors for laboratory, pilot and industrial scale.
The Roche Venture Fund is the name given to the corporate venture fund of the healthcare company Roche. Roche has allocated CHF 500 million to invest in and develop commercially successful innovative life science companies. Roche has been investing in early stage companies as part of collaborations since the early-1990s and independent ofcollaborations since 2002. All equity investments made by Roche in biotech and diagnostics companies (including collaboration investments) are negotiated and managed by the Roche Venture Fund. In the past 20 years, the Roche Venture Fund has invested in over 60 companies globally. Currently, Roche Venture Fund has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific Region. The fund is an evergreen fund with CHF 500 million available of which approximately 40% is currently invested.The Roche Venture Fund is a committed long-term stable investor with sufficient money reserved in their fund for follow-on financing rounds. As part of a multinational healthcare company, the Roche Venture Fund has access to considerable expertise both internally and externally. We co-invest with leading venture funds, including other corporate venture funds, on a regular basis.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series B, Series A, Series C
- United States, United Kingdom, Spain
Portfolio highlights
- DiogenX — Welcome to DiogenX. Explore our pioneering research and innovative therapies aimed at transforming diabetes treatment
- Mironid — Google Analytics is a web analysis service provided by Google. Google utilizes the data collected to track and examine the use of www.mironid.com, to prepare reports on its activities and share them with other Google services. Google may use the data collected to contextualize and personalize the ads of its own advertising network.
- MISSION Therapeutics — Deubiquitylating enzymes: multiple drug opportunities across therapeutic areas
We are an alternative investment manager working on behalf of the world's preeminent institutions. Discover our work, teams, careers and more.
Show more
Investment focus
- Biotechnology, Information Technology, Health Care
- Series A, Series C, Seed
- United States, India, Latvia
Portfolio highlights
- Quant — Quant is a premier quantitative research and investment fund led by engineering, mathematics, and business students at the University of Illinois Urbana-Champaign. We employ state-of-the-art analysis tools like deep learning and natural language processing to gain an edge on financial markets across the globe.
- Yellowbrick Data — Yellowbrick is a SQL data platform built on Kubernetes for enterprise data warehousing, ad-hoc and streaming analytics, AI and BI workloads. Yellowbrick offers unparalleled speed and scalability with minimal infrastructure, deployable across public and private clouds, data centers, laptops and the edge; providing a private data cloud experience that ensures data stays under your control to meet residency and sovereignty needs.
- Texas Stock Exchange — The Texas Stock Exchange will focus on enabling U.S. and global companies to access U.S. equity capital markets and will provide a venue to trade and list public companies and the growing universe of exchange-traded products. TXSE will be a fully electronic, national securities exchange that will seek registration with the U.S. Securities and Exchange Commission.
Founded in 2010, TSVC (formerly TEEC Angel Fund) is proud to be a leading early-stage venture capital fund in Silicon Valley.
Show more
Investment focus
- Software, Artificial Intelligence, Health Care
- Seed, Funding Round, Series A
- United States, China, Canada
Portfolio highlights
- Akool — Akool provides a generative AI platform that supercharges business with personalized premium quality visual content for marketing and advertisement.
- Lumotive — Lumotive is a Seattle-based startup company developing high performance, solid-state lidar for autonomous systems in the automotive, UAV, robotics and related industries. The company's revolutionary beam-steering technology leverages Liquid Crystal Metasurfaces (or LCMs) implemented in mature semiconductor manufacturing processes to deliversmall, inexpensive 3D perception systems with unprecedented performance and reliability. For more information, visit us at www.lumotive.com.
- Place Genomics Corporation — Bio Tech
Alexandria Venture Investments is a venture capital firm that develops work in real estate technology, and healthcare sectors. The company's strategic venture capital platform is Alexandria Venture Investments. Since its inception in 1996, the company has invested in disruptive life science, agrifood tech, and technology companies that aredeveloping transformative new modalities and platforms to meaningfully improve human health.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Canada, France
Portfolio highlights
- Meiogenix — Meiogenix is a biotech company developing breeding technologies to unlock the unexplored genetic diversity of organisms. Meiogenix expands the natural biodiversity and helps developing new products to address global food and industrial challenges.
- nChroma Bio — nChroma Bio's integrated product engine allows for safe, accurate, and targeted in vivo administration, addressing major shortcomings of current genetic medicine techniques.
- Nuvig Therapeutics — Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmunediseases.
Investors by industry
Proptech
Impact
Hardware
Gaming
Google
Consumer
Energy
Climate
Marketplace
FinTech
Health Care
Community
Artificial intelligence
Biotech
EdTech
Sustainability
Venture Capital
Organic Food
Real Estate
Web3
Big Data
Education
Finance
Video Games
Payments
Publishing
Food and Beverage
Financial Services
Retail
Clean Energy
B2B
Photography
Infrastructure
Beauty
Social Media
Android
Art
Digital Media
Social Network
Franchise
Construction
Local
eSports
Legal
Enterprise Software
Internet
Sports
Medical
Email
Wellness
Music
Manufacturing
Mobile
Platforms
Mobile Advertising
Recruiting
Biotechnology
Hospitality
Cannabis
Fitness
Travel
Automotive
Wine And Spirits
Medical Device
Crowdfunding
Social
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Theatre
Film
Life Science
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Celebrity
Software
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
Germany
United Kingdom
India
New Zealand
Canada
Ireland
Australia
United States
South Korea
China
Oceania
Japan
Sri Lanka
Singapore
Europe
Indonesia
South Africa
Vietnam
LATAM
Spain
Armenia
Brazil
Africa
Middle East
Qatar
Asia
Saudi Arabia
Georgia
Ecuador
Bahrain
Faroe Islands
Belize
Egypt
Croatia
Greece
Ghana
Hungary
Finland
Estonia
Costa Rica
Czech Republic
Ethiopia
France
Belgium
Hong Kong
Barbados
Gibraltar
Bermuda
Belarus
Algeria
Chile
Denmark
Liberia
Kuwait
Peru
Bulgaria
Myanmar
Liechtenstein
Morocco
Norway
Mexico
Panama
Lithuania
Nicaragua
Mali
Tajikistan
Lebanon
Mauritius
Togo
Seychelles
Philippines
Israel
Jersey
Malaysia
Malta
Italy
Dominican Republic
Poland
Zimbabwe
Tanzania
Namibia
Iceland
Azerbaijan
Nigeria
Bahamas
Iraq
Puerto Rico
United Arab Emirates
Jamaica
Serbia
Sweden
Honduras
Senegal
Bolivia
Isle of Man
Taiwan
Luxembourg
Rwanda
Tunisia
Pakistan
Albania
Zambia
Slovenia
Sierra Leone
San Marino
Thailand
Uruguay
Portugal
Romania
Grenada
Bangladesh
Argentina
Jordan
Uzbekistan
Russian Federation
Turkey
El Salvador
Ukraine
Uganda
Venezuela
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cyprus
Oman
Latvia
Cameroon
Austria
Switzerland
Colombia
Guatemala
Marshall Islands
Investors in Latvia by industry
Financial Services
Finance
Social Network
Energy
Transportation
Internet
Social Media
Manufacturing
Mobile
Music
FinTech
Enterprise
Health Care
EdTech
SaaS
Marketplace
Artificial intelligence
Hardware
Mobile Apps
Climate
Education
Biotechnology
Biotech
Community
Consumer
Media (entertainment)
Machine Learning
Software
Proptech
Real Estate